{"date":"2025-06-04","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4745-2025-06-04-1919-1c36y98","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-04","time":"19:19:51","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告召開2024年年度股東大會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-06-04 19:19，「代重要子公司合富（中國）醫療科技股份有限公司公告召開2024年年度股東大會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-06-04-1917-1lwi4uv","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-04","time":"19:17:59","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告董事會決議變更股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-06-04 19:17，「代重要子公司合富（中國）醫療科技股份有限公司公告董事會決議變更股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-06-04-1917-g0mtjm","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-04","time":"19:17:11","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-06-04 19:17，「代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-06-04-1727-pk3835","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-06-04","time":"17:27:23","subject":"公告本公司取得經濟部產業發展署出具之「係屬科技事業且具市場性」之意見書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-06-04 17:27，「公告本公司取得經濟部產業發展署出具之「係屬科技事業且具市場性」之意見書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2025-06-04-1658-pr08lc","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2025-06-04","time":"16:58:18","subject":"公告本公司庫藏股買回達一定標準申報","clause":"第35款","fact_date":"2025-06-04","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2025-06-04 16:58，「公告本公司庫藏股買回達一定標準申報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2025-06-04-1612-ds864w","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-06-04","time":"16:12:26","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-04","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2025-06-04 16:12，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-04-1611-1fry2sp","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-04","time":"16:11:26","subject":"公告本公司股票初次上市前現金增資員工認購股款催繳事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-04 16:11，「公告本公司股票初次上市前現金增資員工認購股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-06-04-1602-371jsg","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-06-04","time":"16:02:00","subject":"更正本公司114年股東常會議事手冊及各項議案參考資料(提撥比率誤植)","clause":"第44款","fact_date":"2025-06-04","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-06-04 16:02，「更正本公司114年股東常會議事手冊及各項議案參考資料(提撥比率誤植)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-06-04-1546-ds864w","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-06-04","time":"15:46:40","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-04","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-06-04 15:46，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-06-04-1512-64e64j","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-06-04","time":"15:12:48","subject":"更正公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-06-04 15:12，「更正公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}